newsfilter
← Latest News
Business Wire·

Equillium to Participate in Upcoming Investor Conferences

EQ

Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the